ArticleInternational journal of endocrinology2026
Correlation Between Thyroid Function Parameters and Aldosterone-Renin Ratio in Patients With Primary Aldosteronism and Their Association With Target Organ Damage.
Article in International journal of endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Correlation Between Thyroid Function Parameters and Aldosterone-Renin Ratio in Patients With Primary Aldosteronism and Their Association With Target Organ Damage.International journal of endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary aldosteronism (PA) is one of the most common causes of secondary hypertension. The relationship between thyroid function parameters and the aldosterone-renin ratio (ARR) in PA patients, as well as their combined impact on target organ damage, remains incompletely understood. Methods: We conducted a retrospective analysis of 317 patients with suspected or confirmed PA who underwent comprehensive endocrine evaluation, including thyroid function testing, plasma aldosterone concentration, plasma renin activity (PRA), ARR, and assessment of target organ damage. Biomarker correlation and regression analyses were performed in the whole cohort, while thyroid function subgroup comparisons were restricted to patients with confirmed PA. Suppressed renin activity was predefined as PRA < 1.0 ng/mL/h, with profound suppression defined as PRA < 0.5 ng/mL/h. Results: Among 317 patients (54.9% male, 45.1% female), 229 (72.24%) were diagnosed with PA. Hypertension was present in 248 patients (78.23%), of whom 239 (75.39%) were classified as Grade 3 hypertension with very high cardiovascular risk. Thyroid dysfunction was observed in a subset of patients, with elevated TSH levels present among individuals with hypothyroid status. The mean TSH was 3.86 ± 2.41 μIU/mL, and the mean ARR was 48.058 ± 3.161. Significant correlations were found between TSH and ARR ( Conclusion: Thyroid function parameters, particularly TSH and FT4, are significantly associated with ARR in patients with suspected or confirmed PA. Thyroid dysfunction and elevated ARR are associated with target organ damage, and their combined assessment may improve endocrine and cardiovascular risk stratification in PA-related hypertension.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.